Lucid Diagnostics Stock Probability of Future Stock Price Finishing Over 1.22
| LUCD Stock | USD 1.22 0.02 1.67% |
Lucid Diagnostics Target Price Odds to finish over 1.22
The tendency of Lucid Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.22 | 90 days | 1.22 | about 10.12 |
Based on a normal probability distribution, the odds of Lucid Diagnostics to move above the current price in 90 days from now is about 10.12 (This Lucid Diagnostics probability density function shows the probability of Lucid Stock to fall within a particular range of prices over 90 days) .
Lucid Diagnostics Price Density |
| Price |
Predictive Modules for Lucid Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lucid Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lucid Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lucid Diagnostics is not an exception. The market had few large corrections towards the Lucid Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lucid Diagnostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lucid Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.16 | |
β | Beta against Dow Jones | 0.64 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.04 |
Lucid Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lucid Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lucid Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lucid Diagnostics may become a speculative penny stock | |
| Lucid Diagnostics had very high historical volatility over the last 90 days | |
| Lucid Diagnostics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 4.35 M. Net Loss for the year was (45.53 M) with loss before overhead, payroll, taxes, and interest of (2.56 M). | |
| Lucid Diagnostics currently holds about 34.46 M in cash with (44.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89. | |
| Lucid Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Roughly 35.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from prnewswire.com: PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities |
Lucid Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lucid Stock often depends not only on the future outlook of the current and potential Lucid Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lucid Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.5 M | |
| Cash And Short Term Investments | 22.4 M |
Lucid Diagnostics Technical Analysis
Lucid Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Lucid Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lucid Diagnostics. In general, you should focus on analyzing Lucid Stock price patterns and their correlations with different microeconomic environments and drivers.
Lucid Diagnostics Predictive Forecast Models
Lucid Diagnostics' time-series forecasting models is one of many Lucid Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lucid Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lucid Diagnostics
Checking the ongoing alerts about Lucid Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lucid Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lucid Diagnostics may become a speculative penny stock | |
| Lucid Diagnostics had very high historical volatility over the last 90 days | |
| Lucid Diagnostics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 4.35 M. Net Loss for the year was (45.53 M) with loss before overhead, payroll, taxes, and interest of (2.56 M). | |
| Lucid Diagnostics currently holds about 34.46 M in cash with (44.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89. | |
| Lucid Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Roughly 35.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from prnewswire.com: PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities |
Check out Lucid Diagnostics Analysis, Lucid Diagnostics Valuation, Lucid Diagnostics Correlation, Lucid Diagnostics Hype Analysis, Lucid Diagnostics Volatility, Lucid Diagnostics Price History as well as Lucid Diagnostics Performance. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Health Care Equipment & Supplies sector continue expanding? Could Lucid diversify its offerings? Factors like these will boost the valuation of Lucid Diagnostics. Expected growth trajectory for Lucid significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lucid Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
Understanding Lucid Diagnostics requires distinguishing between market price and book value, where the latter reflects Lucid's accounting equity. The concept of intrinsic value - what Lucid Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Lucid Diagnostics' price substantially above or below its fundamental value.
Understanding that Lucid Diagnostics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lucid Diagnostics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lucid Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.